DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Li J, Qin S, Xu R, Yau TC, Ma B, Pan H. et al.
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol 2015;
16: 619-29
We do not assume any responsibility for the contents of the web pages of other providers.